[MO-6] Three years clinical outcome of endovascular therapy for the critical limb ischemia with below-the knee disease
Backgroud: Endovascular therapy (EVT) have been developed, however patients with critical limb ischemia (CLI) have a poor prognosis. To evaluate long term clinical outcomes after EVT for CLI with below-the knee (BK) disease from daily practice.
Methods: Between 2011 July and 2015 September, 69 patients (102 sessions) with CLI were treated BK interventions. If there were severe stenosis in Iliac and SFA lesions, we enrolled after Iliac and SFA interventions. Indication of EVT was decided by consensus among vascular specialists (including vascular surgeons and intervention cardiologists). We investigated the occurrence of clinical events within 36 months after EVT, such as death, major and minor amputation, revascularization.
Results: Of these patients, mean age was 77 ± 8 years, 58.0% (40/69) was male. Hypertensive patients were 46 (66.7%), Dyslipidemia were 21 (30.4%). Diabetes were 37 (53.6%), prior and current smoker were 31 (44.9%) and Hemodialysis patients were 22 (31.9%). 52.2% (36/69) of all patients have ischemic heart disease. Rutherford class 4 was 13 patients, 5 was 52 patients and 6 was 4 patient. 36 months after EVT (follow up % was 71.0%), there were 20 deaths (40.8%, 12 months mortality was 14.1% and 24 months mortality was 27.6%), 1 major amputation, 23 minor amputations, 4 bypass surgery. 31.9% of all patients were needed revascularizations.
Conclusion: Three year clinical outcomes after EVT for CLI with BK disease were acceptable.
Methods: Between 2011 July and 2015 September, 69 patients (102 sessions) with CLI were treated BK interventions. If there were severe stenosis in Iliac and SFA lesions, we enrolled after Iliac and SFA interventions. Indication of EVT was decided by consensus among vascular specialists (including vascular surgeons and intervention cardiologists). We investigated the occurrence of clinical events within 36 months after EVT, such as death, major and minor amputation, revascularization.
Results: Of these patients, mean age was 77 ± 8 years, 58.0% (40/69) was male. Hypertensive patients were 46 (66.7%), Dyslipidemia were 21 (30.4%). Diabetes were 37 (53.6%), prior and current smoker were 31 (44.9%) and Hemodialysis patients were 22 (31.9%). 52.2% (36/69) of all patients have ischemic heart disease. Rutherford class 4 was 13 patients, 5 was 52 patients and 6 was 4 patient. 36 months after EVT (follow up % was 71.0%), there were 20 deaths (40.8%, 12 months mortality was 14.1% and 24 months mortality was 27.6%), 1 major amputation, 23 minor amputations, 4 bypass surgery. 31.9% of all patients were needed revascularizations.
Conclusion: Three year clinical outcomes after EVT for CLI with BK disease were acceptable.